The Latest Breaking News from diabetes

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer’s, according to two large new studies. The results close the door, for now, on hopes that a treatment for diabetes and obesity might also help protect the brain.

People with higher fitness had greater gluteus maximus shape when compared to those with a sedentary lifestyle

Here's what this new study means for those with type 2 diabetes.

Type 2 diabetes is one of the most common chronic conditions among seniors, and it often leads to hospitalizations, complications, and reduced quality of life....

As a public health dentist and researcher, for years I saw the same pattern. Patients with deep root infections often had wider health problems, particularly those with diabetes. I did not yet understand why. Now, scientific studies are beginning to explain the link: treating a deep tooth infection may also…

Celebrity chefs Jamie Oliver, Hugh Fearnley‑Whittingstall and Tom Kerridge have backed a new campaign that is putting the spotlight on beans. The Bang In Some Beans campaign is a bid to double the UK’s intake of beans, legumes and pulses by 2028.

Mcdonald’s, Wendy’s, Donuts, Starbucks Frappuccinos... Not exactly the healthiest diet for someone with diabetes. Yet, one diabetic woman insists on indulging in such food while at work. Needless to say, she ends up getting ill and as a result, is always behind schedule with her tasks. One of her colleagues…

Novo Nordisk A/S (NYSE:NVO) on Tuesday released headline results from a phase 2 trial with amycretin for type 2 diabetes.

Meghan Trainor opens up about the health scare that triggered her weight-loss journey, discussing gestational diabetes, lifestyle changes and public scrutiny.

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the disease in a trial. Meanwhile, Germany's Bayer said their stroke-prevention drug showed positive results, pushing the share price through the roof.

Some recent national numbers suggest the obesity rate has plateaued or even declined. Experts are skeptical.